Pharming Group (PHAR)
7.53
-0.23
(-2.96%)
USD |
NASDAQ |
Nov 22, 16:00
7.48
-0.05
(-0.66%)
After-Hours: 20:00
Pharming Group Profit Margin (Quarterly): -1.38% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.38% |
| June 30, 2024 | -1.64% |
| March 31, 2024 | -22.39% |
| December 31, 2023 | -3.85% |
| September 30, 2023 | 5.20% |
| June 30, 2023 | 2.40% |
| March 31, 2023 | -28.70% |
| December 31, 2022 | -26.78% |
| September 30, 2022 | 16.78% |
| June 30, 2022 | 31.39% |
| March 31, 2022 | 7.42% |
| December 31, 2021 | 3.91% |
| September 30, 2021 | -0.79% |
| June 30, 2021 | 11.73% |
| March 31, 2021 | 19.56% |
| December 31, 2020 | 14.25% |
| September 30, 2020 | 16.48% |
| June 30, 2020 | 24.54% |
| March 31, 2020 | 17.10% |
| December 31, 2019 | 26.16% |
| September 30, 2019 | 23.44% |
| June 30, 2019 | 16.08% |
| March 31, 2019 | 19.13% |
| December 31, 2018 | 30.86% |
| September 30, 2018 | 13.81% |
| Date | Value |
|---|---|
| June 30, 2018 | 9.51% |
| March 31, 2018 | 18.62% |
| December 31, 2017 | -115.4% |
| September 30, 2017 | -30.77% |
| June 30, 2017 | -153.4% |
| March 31, 2017 | -37.18% |
| December 31, 2016 | -96.93% |
| September 30, 2016 | -108.7% |
| June 30, 2016 | -108.8% |
| March 31, 2016 | -152.9% |
| December 31, 2015 | -185.4% |
| September 30, 2015 | -74.20% |
| June 30, 2015 | -62.70% |
| March 31, 2015 | -74.61% |
| December 31, 2014 | 81.07% |
| September 30, 2014 | 13.17% |
| June 30, 2014 | -137.5% |
| March 31, 2014 | -1.13K% |
| December 31, 2013 | -416.4% |
| September 30, 2013 | -334.4% |
| June 30, 2013 | -42.16% |
| March 31, 2013 | -1.12K% |
| December 31, 2012 | -7.31% |
| September 30, 2012 | -1.54K% |
| June 30, 2012 | -1.16K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-28.70%
Minimum
Mar 2023
31.39%
Maximum
Jun 2022
5.57%
Average
6.31%
Median
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -1.94K% |
| ProQR Therapeutics NV | -211.0% |
| Merus NV | -848.7% |
| argenx SE | 15.95% |
| Pharvaris NV | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.24% |
| Return on Assets | -4.08% |
| Return on Invested Capital | -5.33% |
| Gross Profit Margin (Quarterly) | 90.89% |
| Operating Margin (Quarterly) | 5.49% |
| Return on Net Operating Assets | -8.74% |